Research Papers

19 of 694 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Catching bird flu in a droplet.
Pipper J; Inoue M; Ng LF; Neuzil P; Zhang Y; Novak L.
Nat Med (Unknown)
Published: 2007
2/6 Transparent
Data Funding Declared
Menno de Jong.
Opar A.
Nat Med (Unknown)
Published: 2006
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong MD; Simmons CP; Thanh TT; Hien VM; Smith GJ; Chau TN; Hoang DM; Chau NV; Khanh TH; Dong VC; Qui PT; Cam BV; Ha do Q; Guan Y; Peiris JS; Chinh NT; Hien TT; Farrar J.
Nat Med (Unknown)
Published: 2006
2/6 Transparent
Funding Declared
Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque.
Li BJ; Tang Q; Cheng D; Qin C; Xie FY; Wei Q; Xu J; Liu Y; Zheng BJ; Woodle MC; Zhong N; Lu PY.
Nat Med (Unknown)
Published: 2005
2/6 Transparent
Funding Declared
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.
Oliphant T; Engle M; Nybakken GE; Doane C; Johnson S; Huang L; Gorlatov S; Mehlhop E; Marri A; Chung KM; Ebel GD; Kramer LD; Fremont DH; Diamond MS.
Nat Med (Unknown)
Published: 2005
2/6 Transparent
Funding Declared
Vaccines: past, present and future.
Plotkin SA.
Nat Med (Unknown)
Published: 2005
1/6 Transparent
Severe acute respiratory syndrome.
Peiris JS; Guan Y; Yuen KY.
Nat Med (Unknown)
Published: 2004
2/6 Transparent
Funding Declared
Molecular constraints to interspecies transmission of viral pathogens.
Webby R; Hoffmann E; Webster R.
Nat Med (Unknown)
Published: 2004
2/6 Transparent
Funding Declared
Social and environmental risk factors in the emergence of infectious diseases.
Weiss RA; McMichael AJ.
Nat Med (Unknown)
Published: 2004
1/6 Transparent
From Pasteur to genomics: progress and challenges in infectious diseases.
Rappuoli R.
Nat Med (Unknown)
Published: 2004
1/6 Transparent
Malik Peiris.
Mandavilli A.
Nat Med (Unknown)
Published: 2004
Identification of a new human coronavirus.
van der Hoek L; Pyrc K; Jebbink MF; Vermeulen-Oost W; Berkhout RJ; Wolthers KC; Wertheim-van Dillen PM; Kaandorp J; Spaargaren J; Berkhout B.
Nat Med (Unknown)
Published: 2004
2/6 Transparent
Data
Genetic, cellular and immune approaches to disease therapy: past and future.
Nabel GJ.
Nat Med (Unknown)
Published: 2004
1/6 Transparent
HIV and AIDS: looking ahead.
Weiss RA.
Nat Med (Unknown)
Published: 2003
1/6 Transparent
Funding Declared
A newly discovered human pneumovirus isolated from young children with respiratory tract disease.
van den Hoogen BG; de Jong JC; Groen J; Kuiken T; de Groot R; Fouchier RA; Osterhaus AD.
Nat Med (Unknown)
Published: 2001
1/6 Transparent
Data
A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type…
Pastey MK; Gower TL; Spearman PW; Crowe JE; Graham BS.
Nat Med (Unknown)
Published: 2000
1/6 Transparent
Funding Declared
Primary demyelination in transgenic mice expressing interferon-gamma.
Horwitz MS; Evans CF; Mcgavern DB; Rodriguez M; Oldstone MBA.
Nat Med (Unknown)
Published: 1997
Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase.
Moghaddam MF; Grant DF; Cheek JM; Greene JF; Williamson KC; Hammock BD.
Nat Med (Unknown)
Published: 1997
1/6 Transparent
Funding Declared
Complement-specific antibodies: designing novel anti-inflammatories.
Matis LA; Rollins SA.
Nat Med (Unknown)
Published: 1995